Product logins

Find logins to all Clarivate products below.


Heart Valve Devices | Market Insights | Asia Pacific (Supplemental) | 2023

The Asia Pacific heart valve device market has seen a moderately negative impact due to the global COVID-19 pandemic. However, in the long term, the market will be driven by positive results from THV device clinical trials as well as product launches, resulting in robust growth through 2031.

This Medtech 360 Report provides high-level market metrics for heart valve devices in the Asia Pacific, including country-level data for major countries and aggregate data for the rest of the Asia Pacific from 2019 through 2031.

Related Medtech Insights Reports

Report
Heart Valve Devices – Market Insights – Europe
The European heart valve device market will continue to observe moderate growth, particularly due to growing demand for minimally invasive cardiac interventions boosting the adoption of THV devices…
Report
Interventional Oncology Devices – Market Insights – Asia Pacific
The Asia Pacific interventional oncology device market will see strong growth through 2034, driven by updated clinical guidelines, broader access to minimally invasive cancer treatments, and…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific
The Asia Pacific EP mapping and ablation device market will experience strong growth through 2034, driven by rising procedure volumes, new product launches, increasing prevalence of cardiac…
Report
Sports Medicine Devices – Market Insights – Asia Pacific
Technological investments, adoption of premium-priced products, increased market awareness through educational programs, and improved surgeon training will drive rapid growth in the Asia Pacific…
Report
Aesthetic Injectables – Market Insights – Asia Pacific
The Asia Pacific aesthetic injectable market will continue to expand through 2034, fueled by continuous innovation and the introduction of differentiated products by leading global and regional…